Feasibility of the interferon-gamma enzyme-linked immunospot assay in chronic renal failure patients and immunocompetent subjects: a head-to-head comparison

References

• Girndt M, Sester U, Sester M, Kaul H, Köhler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant. 1999;14:2807–2810
   PubMed Web of Science ®Google Scholar
• Kwan JT, Hart PD, Raftery MJ, Cunningham J, Marsh FP. Mycobacterial infection is an important infective complication in British Asian dialysis patients. J Hosp Infect. 1991;19(4):249
   PubMedGoogle Scholar
• Chia S, Karim S, Elwood RK, Fitzgerald JM. Risk of tuberculosis in dialysis patients: A population-based study. Int J Tuberc Lung Dis. 1998;2:989–991
   PubMed Web of Science ®Google Scholar
• Tuberculosis transmission in a renal dialysis center – Nevada. MMWR Morb Mortal Wkly Report 2004;53:873–875. Joint Statement of the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:221–247
   Google Scholar
• Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; The ESCMID Study Group of Infections in Compromised Hosts (ESGICH). Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(Suppl 7):89–101
   Google Scholar
• Lalvani A. Diagnosing tuberculosis infection in the 21st century. Chest. 2007;131(6):1898–1906
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis. Ann Intern Med. 2008;149(3):177–184
   PubMed Web of Science ®Google Scholar
• Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804–809
   PubMed Web of Science ®Google Scholar
• Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998;31:848–852
   PubMed Web of Science ®Google Scholar
• Dilektasli AG, Erdem E, Durukan E, Eyüboğlu FÖ. Is the T-cell based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country? Jpn J Infect Dis. 2010;63:433–436
   PubMed Web of Science ®Google Scholar
• Rogerson TE, Chen S, Kok J, et al. Tests for latent tuberculosis in people with ESRD: A systematic review. Am J Kidney Dis. 2013;61(1):33–43
   PubMedGoogle Scholar
• Gümüşlü F, Özkara Ş, Özkan S, et al. Childhood tuberculosis, Tuberculin Skin test (TST) and prevention from tuberculosis. In: Gümüşlü F, Özkara Ş, eds. Annual Report on the Tuberculosis Control in Turkey. Ankara: Rekmay; 2007:41–76
   Google Scholar
• The Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376–1395
   Google Scholar
• Öner-Eyuboglu AF, Akcay MS, Arslan H, Demirhan B, Kalpaklioglu AF. Extrapulmonary involvement of Mycobacterial infections in dialysis patients. Transplant Proc. 1999;31:3199–3201
   PubMedGoogle Scholar
• Zhang L, Zhang Y, Shi X, et al. Utility of T-cell interferon-γ release assays for diagnosing tuberculosis serositis: A prospective study in Beijing, China. PLos One. 2014:9(1):e85030
   Google Scholar
• Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001;357:2017–2021
   PubMed Web of Science ®Google Scholar
• Oni T, Patel J, Gideon HP, et al. Enhanced diagnosis of HIV-1 associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J. 2010;36(3):594–600
   PubMedGoogle Scholar
• Dheda K, Lalvani A, Miller RF, et al. Performance of a T-cell based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS. 2005;19(17):2038–2041
   PubMedGoogle Scholar
• Wauters A, Peetermans WE, van den Brande PV, et al. The value of tuberculin skin testing in hemodialysis patients. Nephrol Dial Transplant. 2004;19:433–438
   PubMed Web of Science ®Google Scholar
• Kantarci G, Altinöz H, Şahin S, Manga G, Taşan G. Tuberculin positivity: A serious problem before transplantation in Turkey. Transplant Proc. 2006;38:646–648
   PubMedGoogle Scholar
• Habesoglu MA, Torun D, Demiroglu YZ, et al. Value of tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc. 2007;39:883–886
   PubMedGoogle Scholar
• Lee SS, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients with end-stage renal disease on hemodiaysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009;37(2):96–102
   Google Scholar
• Sester M, Sester U, Clauer P, et al. Tuberculin skin test underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004;65:1826–1834
   PubMed Web of Science ®Google Scholar
• Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2007;2:68–73
   PubMed Web of Science ®Google Scholar
• Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in hemodialysis patients. Clin Microbiol Infect. 2010;16(7):960–965
   PubMedGoogle Scholar
• Soysal A, Toprak D, Koc M, Arikan H, Akoglu E, Bakir M. Diagnosing latent tuberculosis infection in hemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test. Nephrol Dial Transplant. 2012;27(4):1645–1650
   PubMedGoogle Scholar
• Pai M, Riley W, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis. 2004;4:761–776
   PubMed Web of Science ®Google Scholar
• Dheda K, van Zyl Smith R, Badri M, Pai M. T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: Clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med. 2009;15:188–200
   PubMedGoogle Scholar
• Winthrop KL, Nyendak M, Calvet H, et al. Interferon-γ release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol. 2008;3:1357–1363
   PubMed Web of Science ®Google Scholar
• Inoue T, Nakamura T, Katsuma A, et al. The value of QuantiFERON®TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant. 2009;24:2252–2257
   PubMedGoogle Scholar
• Triverio PA, Bridevaux PO, Roux-Lombard P, et al. Interferon-γ release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic hemodialysis patients. Nephrol Dial Transplant. 2009;24:1952–1956
   PubMed Web of Science ®Google Scholar
• Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis. 2008;12(1):50–56
   PubMedGoogle Scholar
• Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-γ secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: Associations with clinical disease state and effect of treatment. J Immunol. 2001;167:5217–5225
   PubMed Web of Science ®Google Scholar
• Girndt M, Sester M, Sester U, Kaul H, Köhler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59:1382–1389
   PubMedGoogle Scholar
• Shankar MSR, Aravindan AN, Sohal PM, et al. The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant. 2005;20:2720–2724
   PubMedGoogle Scholar
• Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113:25–27
   PubMed Web of Science ®Google Scholar
• Vincenti D, Carrara S, Butera O, et al. Response to RD1 epitopes in HIV-infected individuals enrolled with suspected active tuberculosis: A pilot study. Clin Exp Immunol. 2007;150:91–98
   PubMedGoogle Scholar
• Kim SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transplant Infect Dis. 2009;12(2):113–119
   Google Scholar
• Shu CC, Wu VC, Yang FJ, et al. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. PLoS One. 2012;7:e42592
   PubMed Web of Science ®Google Scholar